Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
3530 JOHN HOPKINS COURT, SAN DIEGO, CA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
15 Oct 2026

ImmunityBio, Inc. reported Regulation FD disclosure

ImmunityBio, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

7 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ImmunityBio, Inc..

4 Aug 2026

ImmunityBio, Inc. filed Form 10-Q

ImmunityBio, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

4 Aug 2026

ImmunityBio, Inc. reported Operating or financial results

ImmunityBio, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

31 Jul 2026

ImmunityBio, Inc. reported Regulation FD disclosure

ImmunityBio, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$75.67M
Total assets (USD)$628.50M
Total liabilities (USD)$1.67B
Shareholders' equity (USD)−$1.05B
Debt due within a year (USD)$884,000

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$51.24M−$61.70M−$230.38M−$0.2210-Q · 4 Aug 2026
Q1 2026$44.21M−$69.79M−$632.78M−$0.6210-Q · 7 May 2026
Q4 2025$38.29M−$64.68M−$62.05MUnavailable10-K · 23 Feb 2026
Q3 2025$32.06M−$55.63M−$67.25M−$0.0710-Q · 5 Nov 2025
Q2 2025$26.43M−$71.29M−$92.56M−$0.1010-Q · 5 Aug 2025
Q1 2025$16.52M−$64.43M−$129.65M−$0.1510-Q · 12 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $14.25
63.2% upside potential
📈
Strong Buy
Unavailable
👍
Buy
4
⏸️
Hold
0
📉
Sell
0
4 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 12.00–16.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
5
Oct 2026
Simon Barry J.
Director
Open-market sale
$10.75 per share
25,000 shares
SEC Form 4
2
Oct 2026
Cohen Cheryl
Director
Option exercise
$2.98 per share
55,979 shares
SEC Form 4
2
Oct 2026
Cohen Cheryl
Director
Open-market sale
$10.50 per share
81,056 shares
SEC Form 4
2
Jul 2026
Cohen Cheryl
Director
Option exercise
$2.98 per share
55,979 shares
SEC Form 4
2
Jul 2026
Cohen Cheryl
Director
Open-market sale
$9.50 per share
131,210 shares
SEC Form 4
1
Jul 2026
Selecky Christobel
Director
Option exercise
$2.99 per share
159,478 shares
SEC Form 4
1
Jul 2026
Selecky Christobel
Director
Open-market sale
$9.02 per share
159,478 shares
SEC Form 4
30
Jun 2026
Selecky Christobel
Director
Option exercise
$2.98 per share
1,000 shares
SEC Form 4
30
Jun 2026
Selecky Christobel
Director
Open-market sale
$9.00 per share
1,000 shares
SEC Form 4
29
Jun 2026
Selecky Christobel
Director
Option exercise
$2.94 per share
95,722 shares
SEC Form 4

Top Shareholders

Blackrock, Inc.
34,083,262 shares
29.366% change
6/30/2026
Vanguard Group Inc
32,777,257 shares
18.521% change
12/31/2025
State Street Corp
21,398,438 shares
20.84% change
6/30/2026
Vanguard Portfolio Management Llc
17,863,911 shares
9.441% change
6/30/2026
Vanguard Capital Management Llc
15,691,579 shares
3.727% change
6/30/2026
D. E. Shaw & Co., Inc.
11,551,019 shares
-8.118% change
6/30/2026
Two Sigma Investments, Lp
11,097,106 shares
153.041% change
6/30/2026
Geode Capital Management, Llc
9,847,896 shares
22.609% change
6/30/2026
Millennium Management Llc
5,579,793 shares
292.876% change
6/30/2026
Northern Trust Corp
3,565,248 shares
42.338% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 17 hours ago